SEE AN ISSUE?
If you see an issue with this website, please contact email@example.com.
July 31, 2017
MILWAUKEE — Dr. Qadir Timerghazin, professor of chemistry, is the recipient of this year's Way Klingler Sabbatical Award.
Dr. Qadir Timerghazin's theoretical predictions promise to demystify an elusive biological molecule involved in, among other things, the processes related to Alzheimer's and Parkinson's diseases and heart conditions called S-nitrosothiols.
This award will allow Timerghazin to test his predictions at leading experimental labs at the Medical College of Wisconsin and Georgetown University.
"The development of these ideas will lead to much better molecular-level understanding of physiological and pathological processes involving S-nitrosothiols," Timerghazin says. "But we need solid experimental evidence first."
Theoretical insights from the Timerghazin group can also help to make S-nitrosothiols do our bidding. "We proposed approaches that can dramatically simplify the identification of S-nitrosothiols in living cells, or lead to the development of new molecules of pharmacological interest," he says. "I can't wait to see how they will hold up at the experimental bench.
The Way Klingler Sabbatical Award is nominated annually by the Sabbatical Review Committee.The recipient receives his or her full salary, plus two additional months of summer pay and $10,000 to fund travel and expenses related to research conducted during the year-long sabbatical.
# # #